Full-Time

Manager – Laboratory Operations

Biologics, Mass Spectrometry and Bioseparation

Posted on 9/29/2025

Deadline 9/24/27
Alcami

Alcami

51-200 employees

No salary listed

Durham, NC, USA

In Person

On-site role; 5% travel; 1st shift 8:30–5:30, Mon–Fri.

Category
Biology & Biotech (2)
,
Requirements
  • Doctorate degree with 8+ years, or Master’s degree with 10+ years, or Bachelor’s degree with 12+ years of related experience in Chemistry, Biochemistry, or related field.
  • 2+ years of previous supervisory experience.
  • Experience in development, validation, and verification of analytical testing methods.
  • Experience with inspections/audits by regulatory agencies and clients.
  • Previous experience within CMO, or CDMO preferred.
  • Previous experience in pharmaceutical GMP environment required.
Responsibilities
  • Acts as the primary point of contact for key biologics clients, ensuring exceptional customer service and responsiveness.
  • Oversee analytical services supporting biologics and other large molecules, including bioseparations using a variety of chromatographic and electrophoretic methodologies, characterization, release, stability testing, and other specialty studies.
  • Extensive experience with mass spectrometry as applied to biologics, including method development, characterization, troubleshooting of instrumentation, data interpretation, and application of advanced analytical techniques to complex biologics.
  • Translate client needs into actionable project plans while balancing scientific rigor with business requirements.
  • Serve as subject matter expert in Biologics for internal and external stakeholders.
  • Ensure projects are executed on time, on budget, and to the highest quality standards.
  • Lead capacity planning, resource allocation, and prioritization of biologics projects across the analytical team.
  • Drive operational efficiency, technical advancements, and laboratory innovation.
  • Foster a culture of quality, compliance, scientific excellence, and continuous improvement.
  • Drive professional development, technical training, and succession planning for staff.
  • Attract, develop, and retain a high performing team to meet the current and evolving needs of the business through effective selection, training and development, coaching and mentoring and performance management.
  • Promote a collaborative and innovative environment that encourages problem-solving and accountability.
  • Ensure adherence to SOPs, training, and other regulatory requirements.
  • Stays current on industry and regulatory laboratory trends and adapts the quality systems, practices, and procedures, as necessary.
Desired Qualifications
  • Proven experience in CDMO/CMO environment desired.
  • Thorough knowledge of GMP requirements and regulatory compliance.
  • Understanding of biologics modalities (mAbs, proteins, cell & gene therapies, etc.) and analytical methodology (HPLC/UPLC, electrophoresis, mass spectrometry, AUC, UV/Vis, potency assays, etc.).
  • Demonstrated success in building and leading teams, driving operational performance and achieving business growth.
  • Excellent communication and interpersonal skills with ability to effectively represent the organization holistically to external clients.
  • Demonstrated business acumen with ability to balance scientific excellence and commercial priorities.
  • Demonstrated experience representing analytical or biologics operations during regulatory inspections.
  • Strong organization and management skills required.
  • Record of accomplishment in change management and proven ability to build teams.
  • Self-motivated with high-energy and an entrepreneurial team spirit, willing to get “hands on” to build the business.
  • Excellent written and verbal communications and presentation skills required.
  • Strong skills with Microsoft Office (Word, Excel, and PowerPoint) required.
  • Travel up to 5% travel required.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Pepperell, Massachusetts

Founded

1984

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquired Pacific Pharmaceutical Services in January 2024, expanding Nevada warehousing.
  • Garner facility expanded January 2025 with stability chambers and inventory management.
  • Backed by GHO Capital, Vistria Group, and Ampersand for CDMO growth.

What critics are saying

  • Patrick Walsh returns as interim CEO January 2025 after Humphries' two-year tenure.
  • No disclosed synergies from 2024 Pacific and 2021 Masy acquisitions erode margins.
  • Garner facility cannibalizes existing six-location network, compressing storage pricing.

What makes Alcami unique

  • Alcami integrates lab, manufacturing, and cGMP storage across six U.S. locations.
  • Garner facility offers cryogenic LN2, ultra-low freezer, and aliquoting services.
  • Acquired Masy Systems in 2021 for specialized biostorage and support.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

PR Newswire
Jan 13th, 2025
Alcami Announces Ceo Transition

Long time industry leader, Chairman of the Board Patrick Walsh replaces CEO Bill Humphries DURHAM, N.C., Jan. 13, 2025 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the resignation of Bill Humphries. Alcami's Board Chair and former Chief Executive Officer Patrick Walsh will serve as Interim CEO, ensuring the continuation of smooth operations and a strong client-centric approach from a proven industry veteran

PR Newswire
Jul 23rd, 2024
Alcami Unveils New Conditions And Services At State-Of-The-Art Pharma Storage Facility In Garner

"Alcami's new facility is well positioned to fill previously unmet market demand," said Laurent Boer, President, Alcami Pharma Storage and Services. "The pipeline of complex medicines – exactly the type of ground-breaking products that life science companies in RTP work on – is only increasing. The biopharmaceutical materials and products in these drugs require very specific warehouse conditions that this new facility provides. But what truly sets us apart as a CDMO is our ability to offer a comprehensive pharma storage network paired with seamless access to our integrated laboratory and manufacturing services. From development to delivery, Alcami has the capabilities to care for and secure product within our own network, reducing risk and streamlining efficiency."After opening in January with controlled/ambient storage, the facility can now accept shipments for an extensive range of storage conditions, including stability chamber storage, refrigerated storage, freezer, ultra-low freezer, and cryogenic storage (LN2) as well as custom conditions. In addition, the site now offers a full suite of materials management and support services that facilitate the full product development, storage, and commercialization journey, including onsite aliquoting/sampling in grade C sampling booths, refrigerated transport, labeling, cycle counting/inventory management, custom kitting, and reference standards management.The new central North Carolina facility adjacent to the Research Triangle Park expands Alcami's high-quality, secure GMP storage network to six U.S

Contract Pharma
Dec 15th, 2021
alcami acquires Masy Systems Inc.

Alcami Corp., a pharmaceutical and biotech contract development and manufacturing organization ( CDMO ), has completed the acquisition of Masy Systems Inc., a provider of cGMP biostorage and pharma support services.

PR Newswire
Dec 15th, 2021
AAIPharma Services Corp. acquired Masy Systems Inc. on Dec 15th 21'.

Alcami Corporation, a leading pharmaceutical and biotech contract development and manufacturing organization (CDMO), announced today it has completed the acquisition of Masy Systems Inc. ("Masy" or "Masy BioServices"), a preferred provider of cGMP Biostorage and pharma support services.

Daily Times Chronicle
Dec 1st, 2021
Masy Systems Inc. launches SenseAnywhere modules

Masy BioServices announces the launch of innovative SenseAnywhere modules.

INACTIVE